Nasdaq
TRAX
First Tracks Biotherapeutics, Inc.
- Health Care
- 1 day
- −3.5%
- 1 month
- +129%
- 1 year
- —
$45.31 · Mkt cap $1.58B
At the 6 Aug 2026 close
Nasdaq
First Tracks Biotherapeutics, Inc.
$45.31 · Mkt cap $1.58B
At the 6 Aug 2026 close
First Tracks Biotherapeutics, Inc. trades under the ticker TRAX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $1.58B. The last closing price was $45.31, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because TRAX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.